| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Bostofte E et al. | Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation. | 1978 | Acta Endocrinol. | pmid:347855 |
| Varma SK and Bloch E | Effects of prenatal administration of mestranol and two progestins on testosterone synthesis and reproductive tract development in male rats. | 1987 | Acta Endocrinol. | pmid:2958983 |
| JelÃnek J et al. | Effect of two progestins on human endometrial enzymes and trace elements. | 1978 | Acta Endocrinol. | pmid:581024 |
| Weiner E and Johansson ED | The influence of norethisterone oenanthate on ovarian function. | 1976 | Acta Endocrinol. | pmid:989667 |
| KRAAY RJ and BRENNAN DM | Evaluation of chlormadinone acetate and other progestogens for foetal masculinization in rats. | 1963 | Acta Endocrinol. | pmid:14035354 |
| Mauvais-Jarvis P et al. | [In vivo studies on metabolism of androgens following administration of steroid inhibitors of ovulation. 1. Changes in the secretion of androgens and excretion of their metabolites in normal subjects and women with the Stein-Leventhal syndrome]. | 1965 | Acta Endocrinol. | pmid:5897059 |
| Larsson-Cohn U et al. | Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens. | 1970 | Acta Endocrinol. | pmid:5468622 |
| Carlborg L et al. | Effect of norethisterone acetate with or without ethinyl oestradiol on the sialic acid concentration and sperm receptivity of the cervical mucus. | 1968 | Acta Endocrinol. | pmid:5757032 |
| Plate WP | Ovarian changes after long-term oral contraception. | 1967 | Acta Endocrinol. | pmid:6071598 |
| Murugesan K et al. | In vitro metabolism of 6,7-3H) norethynodrel in the human endometrium and the myometrium. | 1973 | Acta Endocrinol. | pmid:4800856 |
| Loraine JA et al. | Hormone excretion patterns during and ater the long-term administration of oral contraceptives. | 1965 | Acta Endocrinol. | pmid:5897062 |
| Odlind V and Johansson ED | Free norethisterone as reflected by saliva concentrations of norethisterone during oral contraceptive use. | 1981 | Acta Endocrinol. | pmid:7197450 |
| Hagen C et al. | Long-term effects of oestrogens in combination with gestagen on plasma prolactin and FSH levels in post-menopausal women. | 1982 | Acta Endocrinol. | pmid:6812338 |
| Hoppen HO and Hammann P | The influence of structural modification on progesterone and androgen receptor binding of norethisterone. Correlation with nuclear magnetic resonance signals. | 1987 | Acta Endocrinol. | pmid:3618086 |
| MartÃnez-Manautou J et al. | The ultrastructure of liver cells in women under steroid therapy. II. Contraceptive therapy. | 1970 | Acta Endocrinol. | pmid:4097029 |
| Larsson-Cohn U et al. | Effects of continuous daily administration of 0.3 mg of norehtindrone on the plasma levels of progesterone and on the urinary excretion of pregnanediol and total oestrogens. | 1970 | Acta Endocrinol. | pmid:4195422 |
| Nuttal ID and Elstein M | Steroid releasing vaginal rings. | 1980 | Acta Eur. Fertil. | pmid:6781195 |
| Beck LR and Cowsar D | Biodegradable microsphere contraceptive system. | 1980 | Acta Eur. Fertil. | pmid:7211111 |
| De Cecco L et al. | Effectiveness of norethisterone enantate in the treatment of the climacteic syndrome. | 1982 | Acta Eur. Fertil. | pmid:7186258 |
| Kesserü-Koós E et al. | Fertility control with norethindrone enanthate, a long-acting parenteral progestogen. | 1973 | Acta Eur. Fertil. | pmid:4802108 |